STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.